Compare ZURA & PDLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZURA | PDLB |
|---|---|---|
| Founded | 2022 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 405.9M |
| IPO Year | N/A | 2017 |
| Metric | ZURA | PDLB |
|---|---|---|
| Price | $4.35 | $17.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $11.38 | N/A |
| AVG Volume (30 Days) | ★ 369.0K | 105.7K |
| Earning Date | 11-13-2025 | 01-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 142.83 |
| EPS | N/A | ★ 0.89 |
| Revenue | N/A | ★ $96,252,000.00 |
| Revenue This Year | N/A | $10.97 |
| Revenue Next Year | N/A | $8.59 |
| P/E Ratio | ★ N/A | $19.13 |
| Revenue Growth | N/A | ★ 26.04 |
| 52 Week Low | $0.97 | $10.88 |
| 52 Week High | $4.68 | $18.01 |
| Indicator | ZURA | PDLB |
|---|---|---|
| Relative Strength Index (RSI) | 65.25 | 65.42 |
| Support Level | $3.88 | $16.87 |
| Resistance Level | $4.45 | $17.80 |
| Average True Range (ATR) | 0.25 | 0.43 |
| MACD | 0.05 | 0.06 |
| Stochastic Oscillator | 89.36 | 66.41 |
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.